These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37811353)

  • 1. A Prospective Multicenter Study of a Weekly Application Regimen of Viable Human Amnion Membrane Allograft in the Management of Nonhealing Diabetic Foot Ulcers.
    Galiano RD; Orgill DP; Armstrong DG; Glat PM; Carter MJ; Zelen CM
    Plast Reconstr Surg Glob Open; 2023 Oct; 11(10):e5291. PubMed ID: 37811353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Zelen CM
    Plast Reconstr Surg Glob Open; 2016 Oct; 4(10):e1095. PubMed ID: 27826487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
    Armstrong DG; Galiano RD; Orgill DP; Glat PM; Carter MJ; Di Domenico LA; Reyzelman AM; Zelen CM
    Int Wound J; 2022 May; 19(4):932-944. PubMed ID: 35080127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
    Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC
    Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations.
    Glat P; Orgill DP; Galiano R; Armstrong D; Serena T; DiDomenico LA; Kaufman J; Carter MJ; Jacobs AM; Zelen CM
    Plast Reconstr Surg Glob Open; 2019 Aug; 7(8):e2371. PubMed ID: 31592387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of a Viable Human Amnion Membrane Allograft in Elderly Patients With Chronic Lower Extremity Wounds of Various Etiologies.
    Regulski M
    Wounds; 2018 Mar; 30(3):E36-E40. PubMed ID: 29584608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Skin Allograft for Patients With Diabetic Foot Ulcers, Venous Leg Ulcers, or Surgical/Traumatic Wounds Retrospective, Descriptive Study.
    Desman E; Bartow W; Anderson LH
    Ostomy Wound Manage; 2015 Jul; 61(7):16-22. PubMed ID: 26185972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
    Sledge I; Maislin D; Bernarducci D; Snyder R; Serena TE
    J Wound Care; 2020 Sep; 29(Sup9):S8-S12. PubMed ID: 32924804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft.
    Sanders L; Landsman AS; Landsman A; Keller N; Cook J; Cook E; Hopson M
    Ostomy Wound Manage; 2014 Sep; 60(9):26-38. PubMed ID: 25211605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
    J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of dehydrated human amniotic membrane allografts in patients with DFUs.
    Zelen CM
    J Wound Care; 2013 Jul; 22(7):347-8, 350-1. PubMed ID: 24159656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
    Zelen CM; Serena TE; Snyder RJ
    Int Wound J; 2014 Apr; 11(2):122-8. PubMed ID: 24618401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience using a dehydrated amnion/chorion membrane construct for the management of wounds.
    Caporusso J; Abdo R; Karr J; Smith M; Anaim A
    Wounds; 2019 Apr; 31(4 Suppl):S19-S27. PubMed ID: 30933904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.